Bausch Health Companies Inc. (BHC) stock
BHCNYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 8/3075% below fair value
$8.73+0.26 (+3.07%)
Close on Nov 18, 2026Market cap $3.27BP/E –Yield –
Bausch Health Companies pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Bausch Health Companies's pe ratio was 13.6× on Apr 30, 2026, against 54.2× a year earlier. Over the last 5 years it ranged from 2.3× to 736.9×, with a median of 51.0×.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Apr 30, 2026 | 13.6× | +6.5 |
| 2025 | Dec 31, 2025 | 7.2× | −3.8 |
| 2023 | Jan 31, 2023 | 11.0× | +2.0 |
| 2022 | Dec 30, 2022 | 9.0× | +6.3 |
| 2018 | Apr 30, 2018 | 2.6× | −2.7 |
| 2017 | Dec 29, 2017 | 5.3× | −45.6 |
| 2016 | Jan 29, 2016 | 51.0× | −6.5 |
| 2015 | Dec 31, 2015 | 57.4× | −41.3 |
| 2014 | Dec 31, 2014 | 98.7× | −638.2 |
| 2013 | Jan 31, 2013 | 736.9× | +72.8 |
| 2012 | Dec 31, 2012 | 664.1× | +451.9 |
| 2011 | Dec 30, 2011 | 212.2× | +185.5 |
| 2010 | Jan 29, 2010 | 26.8× | +1.3 |
| 2009 | Dec 31, 2009 | 25.4× | – |
See a number that looks wrong?